AI-generated summary
This single-center randomized trial compared low-level laser therapy at 804 nm, Bioptron light therapy, and controls after total knee arthroplasty, with 15 patients per group. The authors report better range of motion, less swelling, lower opioid use and lower pain at 3 months in the laser group, with differences at 12 months less clear. The sample was small and single-surgeon, so the authors frame the benefits as possibly helpful in early recovery.
- Who or what was studied
- Adults undergoing primary total knee arthroplasty, randomized into three groups of 15 patients each (LLLT, Bioptron light, controls).
- Wavelengths
- 804 nm
- Limits stated in the abstract
- The trial was small, single-center and single-surgeon, and the abstract's conclusions are framed as tentative (could be helpful) rather than definitive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 804 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.